, Primary Pulmonary Hypertension in Families with Hereditary Haemorrhagic Telangiectasia, vol.23, pp.373-77, 2004.
« Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Haemorrhagic Telangiectasia, Journal of Internal Medicine, vol.285, issue.2, pp.223-254, 2019. ,
KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension, Potassium Channel Subfamily K Member, vol.3, issue.14, pp.1371-85 ,
, Anti-Angiogenic Therapeutic Strategies in Hereditary Hemorrhagic Telangiectasia, vol.6, p.35, 2015.
« Endoglin, an Ancillary TGFbeta Receptor, Is Required for Extraembryonic Angiogenesis and Plays a Key Role in Heart Development, Developmental Biology, vol.217, issue.1, pp.42-53, 2000. ,
An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension, Journal of Medicinal Chemistry, vol.58, issue.18, pp.7128-7165 ,
« Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-Receptor », The Journal of Biological Chemistry, vol.280, pp.29820-29847 ,
,
, Bringing New Life to Shelved Assets and Existing Drugs. ». ChemMedChem, vol.8, issue.2, pp.336-373, 2013.
, Strength and specificity of the CMBA screening platform for bioactive molecules discovery] ». Medecine Sciences: M/S 31, pp.423-454, 2015.
« A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension, The New England Journal of Medicine, vol.334, issue.5, pp.296-301, 1996. ,
« BMPR-II Heterozygous Mice Have Mild Pulmonary Hypertension and an Impaired Pulmonary Vascular Remodeling Response to Prolonged Hypoxia, American Journal of Physiology. Lung Cellular and Molecular Physiology, vol.287, issue.6, pp.1241-1247, 2004. ,
« BMP9 Is Produced by Hepatocytes and Circulates Mainly in an Active Mature Form Complexed to Its Prodomain ». Cellular and Molecular Life Sciences: CMLS 69, pp.313-337, 2012. ,
, High-Throughput RT-PCR for Small-Molecule Screening Assays
« A Murine Model of Hereditary Hemorrhagic Telangiectasia, The Journal of Clinical Investigation, vol.104, issue.10, pp.1343-51, 1999. ,
« Highthroughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth, International Journal for Parasitology: Drugs and Drug Resistance, vol.8, issue.1, pp.137-181, 2018. ,
, Bone Morphogenetic Proteins: A Critical Review, vol.23, pp.609-629, 2011.
Catherine Godson, et Finian Martin. « BMP Signalling: Agony and Antagony in the Family », Trends in Cell Biology, vol.25, issue.5, pp.249-64, 2015. ,
, Intravenous and Topical Intranasal Bevacizumab (Avastin) in Hereditary Hemorrhagic Telangiectasia, vol.33, pp.349-51, 2012.
« Crystal Structure of BMP-9 and Functional Interactions with pro-Region and Receptors, The Journal of Biological Chemistry, vol.280, pp.25111-25129 ,
« Trente ans d'étude de la maladie de Rendu-Osler en France : démographie historique, génétique des populations et biologie moléculaire, vol.64, pp.305-330, 2009. ,
, BMP Signaling in Vascular Diseases, vol.586, pp.1993-2002
Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth, The Journal of Biological Chemistry, vol.286, pp.30034-30080 ,
« Identification of Transforming Growth Factor Beta Family Members Present in Bone-Inductive Protein Purified from Bovine Bone, Proceedings of the National Academy of Sciences of the United States of America, vol.87, pp.9843-9890, 1990. ,
, Long-Term Therapy with Thalidomide in Hereditary Hemorrhagic Telangiectasia: Case Report and Literature Review, vol.52, pp.1436-1476, 2012.
« BMP10 Is Essential for Maintaining Cardiac Growth during Murine Cardiogenesis, vol.131, pp.2219-2250, 2004. ,
,
« Context-Dependent Signaling Defines Roles of BMP9 and BMP10 in Embryonic and Postnatal Development, Proceedings of the National Academy of Sciences of the United States of America, vol.110, pp.11887-92 ,
« Upregulation of ID Protein by Growth and Differentiation Factor 5 (GDF5) through a Smad-Dependent and MAPK-Independent Pathway in HUVSMC, Journal of Molecular and Cellular Cardiology, vol.41, issue.1, pp.26-33, 2006. ,
« Effect of Percutaneous Transcatheter Embolization on Pulmonary Function, Right-to-Left Shunt, and Arterial Oxygenation in Patients with Pulmonary Arteriovenous Malformations ». The American Review of Respiratory Disease 142, pp.420-445, 1990. ,
,
, International Union of Pharmacology Classification of Prostanoid Receptors: Properties, Distribution, and Structure of the Receptors and Their Subtypes, vol.46, pp.205-234
Realdo (1510?-1559) Auteur du texte. De re anatomica libri XV, p.1559 ,
« Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs, Pharmacological reviews, vol.69, issue.4, pp.479-96, 2017. ,
, Peter ten Dijke, et Kristian Pietras. « Genetic and Pharmacological Targeting of Activin Receptor-like Kinase 1 Impairs Tumor Growth and Angiogenesis, vol.207, pp.85-100
« Emerging Role of Bone Morphogenetic Proteins in Angiogenesis, Cytokine & Growth Factor Reviews, vol.20, issue.3, pp.203-215, 2009. ,
, Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor, vol.102, pp.914-936
URL : https://hal.archives-ouvertes.fr/inserm-00277236
« Identification of BMP9 and BMP10 as Functional Activators of the Orphan Activin Receptorlike Kinase 1 (ALK1) in Endothelial Cells, Blood, vol.109, issue.5, pp.1953-61 ,
,
A) and ET(B) Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.3, pp.398-405, 2002. ,
« Familial Primary Pulmonary Hypertension (Gene PPH1) Is Caused by Mutations in the Bone Morphogenetic Protein Receptor-II Gene, American Journal of Human Genetics, vol.67, issue.3, pp.737-781, 2000. ,
« Smad-Dependent and Smad-Independent Pathways in TGF-Beta Family Signalling », Nature, vol.425, pp.577-84, 2003. ,
« Venous Malformation: Update on Aetiopathogenesis, Diagnosis and Management, Phlebology, vol.25, issue.5, pp.224-259, 2010. ,
, The Lysosomal Inhibitor, Chloroquine, Increases Cell Surface BMPR-II Levels and Restores BMP9 Signalling in Endothelial Cells Harbouring BMPR-II Mutations, vol.22, pp.3667-79
, Long-Term Outcome of Patients with Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Involvement after Orthotopic Liver Transplantation: A Single-Center Study ». Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol.16, pp.340-387, 2010.
Adeline Roux, et al. « Bevacizumab in Patients with Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output, JAMA, vol.307, issue.9, pp.948-55 ,
« Pulmonary Arteriovenous Malformations: Results of Treatment with Coil Embolization, p.53 ,
, American Journal of Roentgenology, vol.165, issue.5, pp.1119-1144, 1995.
« Characterization of Bone Morphogenetic Protein-6 Signaling Pathways in Osteoblast Differentiation », Journal of Cell Science, vol.112, pp.3519-3546 ,
Romain Vanwijck, et Miikka Vikkula. « Capillary Malformation-Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations, American Journal of Human Genetics, vol.73, issue.6, pp.1240-1289, 2003. ,
,
Intracellular cyclophilin A is an important Ca 2+ regulator in platelets and critically involved in arterial thrombus formation, Blood, vol.120, issue.6, p.1317, 2012. ,
« Blessing for the Bleeder: Bevacizumab in Hereditary Hemorrhagic Telangiectasia, Clinical Medicine & Research, vol.13, issue.1, pp.32-35, 2015. ,
« International Guidelines for the Diagnosis and Management of Hereditary Haemorrhagic Telangiectasia, Journal of Medical Genetics, vol.48, issue.2, pp.73-87, 2011. ,
, Pazopanib May Reduce Bleeding in Hereditary Hemorrhagic Telangiectasia, vol.22, pp.145-55, 2019.
« Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment with Bevacizumab, The American Journal of the Medical Sciences, vol.343, issue.3, pp.249-51, 2012. ,
« Dramatic Improvement in Hereditary Hemorrhagic Telangiectasia after Treatment with the Vascular Endothelial Growth Factor (VEGF) Antagonist Bevacizumab », Annals of Hematology, vol.85, issue.9, pp.631-663, 2006. ,
, Anti-VEGF with 3-Week Intervals Is Effective on Anemia in a Patient with Severe Hereditary Hemorrhagic Telangiectasia, vol.90, pp.611-623, 2011.
, Bevacizumab Treatment in Hereditary Hemorrhagic Teleangiectasia, vol.68, pp.1685-86, 2012.
« Novel Treatments for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review of the Clinical Experience with Thalidomide, Journal of Thrombosis and Thrombolysis, vol.36, issue.3, pp.355-57, 2013. ,
« Development of the Retinal Vasculature, Angiogenesis, vol.10, issue.2, pp.77-88, 2007. ,
, Implications of Mutations of Activin Receptor-like Kinase, vol.1
, Addition to Bone Morphogenetic Protein Receptor II Gene (BMPR2) in Children with Pulmonary Arterial Hypertension, Circulation Journal: Official Journal of the Japanese Circulation Society, vol.72, issue.ALK1, pp.127-160, 2008.
Tranexamic Acid for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients: A European Cross-over Controlled Trial in a Rare Disease, Journal of Thrombosis and Haemostasis: JTH, vol.12, issue.9, pp.1494-1502, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02071525
« Regulation of Notch Signaling Genes during BMP2-Induced Differentiation of Osteoblast Precursor Cells, Biochemical and Biophysical Research Communications, vol.320, issue.1, pp.100-107 ,
, Identification of Novel Regulators Associated with Early-Phase Osteoblast Differentiation, vol.19, pp.947-58, 2004.
« Hereditary Haemorrhagic Telangiectasia: A Clinical and Scientific Review, European Journal of Human Genetics: EJHG, vol.17, issue.7, pp.860-71, 2009. ,
« Annexin A6 Stimulates the Membrane Recruitment of P120GAP to Modulate Ras and Raf-1 Activity, Oncogene, vol.24, pp.5809-5829 ,
« New Molecular Targets of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension: Importance of Endothelial Communication, vol.147, pp.529-566, 2015. ,
« Pulmonary Arteriovenous Malformations: Effect of Embolization on Right-to-Left Shunt, Hypoxemia, and Exercise Tolerance in 66 Patients, AJR. American Journal of Roentgenology, vol.179, issue.2, pp.347-55, 2002. ,
Earliest Evidence of Cartilage and Bone Development in Embryonic Life, Clinical Orthopaedics and Related Research, issue.225, pp.255-72, 1987. ,
« Follow-up of Thalidomide Treatment in Patients with Hereditary Haemorrhagic Telangiectasia, Rhinology, vol.53, issue.4, pp.340-384, 2015. ,
« Myocardin Regulates BMP10 Expression and Is Required for Heart Development, The Journal of Clinical Investigation, vol.122, issue.10, pp.3678-91, 2012. ,
« Combination of Bosentan with Epoprostenol in Pulmonary Arterial Hypertension: BREATHE-2 », The European Respiratory Journal, vol.24, issue.3, pp.353-59, 2004. ,
« Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.151, issue.5, pp.1628-1659, 1995. ,
,
Riociguat for the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue Disease: Results from PATENT-1 and PATENT-2 », Annals of the Rheumatic Diseases, vol.76, issue.2, pp.422-448, 2017. ,
« Advances in Therapeutic Interventions for Patients with Pulmonary Arterial Hypertension, Circulation, vol.130, pp.2189-2208, 2014. ,
« Cellular and molecular pathobiology of pulmonary arterial hypertension, Journal of the American College of Cardiology, vol.43, pp.13-24 ,
« Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist, The Journal of Pharmacology and Experimental Therapeutics, vol.327, issue.3, pp.736-781, 2008. ,
« Efficacy and Safety of Thalidomide for the Treatment of Severe Recurrent Epistaxis in Hereditary Haemorrhagic Telangiectasia: Results of a Non-Randomised, Single-Centre, Phase 2 Study, The Lancet. Haematology, vol.2, issue.11, pp.195-202, 2015. ,
« Smad6 Is a Smad1/5-Induced Smad Inhibitor. Characterization of Bone Morphogenetic Protein-Responsive Element in the Mouse Smad6 Promoter, The Journal of Biological Chemistry, vol.275, issue.9, pp.6075-79 ,
,
, Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding, vol.93, pp.155-66, 2018.
« Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial ». Circulation, vol.127, issue.5, pp.624-657 ,
« Mutations in the Activin Receptor-like Kinase 1 Gene in Hereditary Haemorrhagic Telangiectasia Type 2 », Nature Genetics, vol.13, issue.2, pp.189-95, 1996. ,
« Developmental Patterning in Chondrocytic Cultures by Morphogenic Gradients: BMP Induces Expression of Indian Hedgehog and Noggin », Genes to Cells: Devoted to Molecular & Cellular Mechanisms, vol.4, issue.3, pp.175-84, 1999. ,
« Identification of a BMP-Responsive Element in Id1, the Gene for Inhibition of Myogenesis, Genes to Cells: Devoted to Molecular & Cellular Mechanisms, vol.7, issue.9, pp.949-60, 2002. ,
, Bone Morphogenetic Proteins, vol.8
, Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase ». Science, vol.271, pp.360-62
« Selective Effects of Oral Antiangiogenic Tyrosine Kinase Inhibitors on an Animal Model of Hereditary Hemorrhagic Telangiectasia, Journal of Thrombosis and Haemostasis: JTH, vol.15, issue.6, pp.1095-1102, 2017. ,
« Intranasal Tranexamic Acid Treatment for Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia, Bone Morphogenetic Protein 4 Mediates Apoptosis of Capillary Endothelial Cells during Rat Pupillary Membrane Regression, vol.23, p.767, 2001. ,
Aris Economides, Takenobu Katagiri, et Vicki Rosen. « BMP3 Suppresses Osteoblast Differentiation of Bone Marrow Stromal Cells via Interaction with Acvr2b, Molecular Endocrinology, vol.26, issue.1, pp.87-94, 2012. ,
,
« Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-Specific Response Elements in the Id1 Promoter, The Journal of Biological Chemistry, vol.277, issue.7, pp.4883-91 ,
« Nintedanib as a Novel Treatment Option in Hereditary Haemorrhagic Telangiectasia, BMJ Case Reports, 2017. ,
Using Thalidomide in a Patient with Epithelioid Leiomyosarcoma and Osler-Weber-Rendu Disease, Oncology, vol.16, issue.1, pp.21-24, 2002. ,
, Nature, vol.156, pp.576-576, 1945.
« Epidemiology and Treatment of Pulmonary Arterial Hypertension », Nature Reviews. Cardiology, vol.14, issue.10, pp.603-617, 2017. ,
Auteur du texte. Traité élémentaire de chimie. Tome 1 / , présenté dans un ordre nouveau, et d'après les découvertes modernes ; avec figures : par M. Lavoisier, Seconde édition, 1793, pp.1743-1794 ,
Dimitrios Tzilves, et Anestis Tarpangos. « Low Dose of Bevacizumab Is Safe and Effective in Preventing Bleeding Episodes in Hereditary Hemorrhagic Telangiectasia, The American Journal of Gastroenterology, vol.106, issue.12, pp.2204-2210, 2011. ,
, et Alain Taïeb. « Propranolol for Severe Hemangiomas of Infancy, vol.358, pp.2649-51
Stieneke van den Brink, Catarina Freitas, Christiane Bréant, et al. « Thalidomide Stimulates Vessel Maturation and Reduces Epistaxis in Individuals with Hereditary Hemorrhagic Telangiectasia », Nature Medicine, vol.16, issue.4, pp.420-448, 2010. ,
« The Transforming Growth Factor-Beta Type III Receptor Mediates Distinct Subcellular Trafficking and Downstream Signaling of Activin-like Kinase (ALK)3 and ALK6 Receptors, Molecular Biology of the Cell, vol.20, pp.4362-70, 2009. ,
, Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry, vol.244, pp.854-862, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00515733
BMP9) Controls Lymphatic Vessel Maturation and Valve Formation, Bone Morphogenetic Protein, vol.9, issue.4, pp.598-607 ,
, Defective Angiogenesis in Mice Lacking Endoglin ». Science, vol.284, pp.1534-1571
« The Cysteine-Rich Domain Protein KCP Is a Suppressor of Transforming Growth Factor Beta/Activin Signaling in Renal Epithelia, Molecular and Cellular Biology, vol.26, issue.12, pp.4577-85, 2006. ,
« The Biological Function of Type I Receptors of Bone Morphogenetic Protein in Bone, Bone Research, vol.4, p.16005 ,
« Dosage-Dependent Requirement of BMP Type II Receptor for Maintenance of Vascular Integrity, Blood, vol.110, issue.5, pp.1502-1512, 2007. ,
,
Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2-Deficient Mice, Circulation Research, vol.98, issue.6, pp.818-845 ,
,
« Direct Binding of Smad1 and Smad4 to Two Distinct Motifs Mediates Bone Morphogenetic Protein-Specific Transcriptional Activation of Id1 Gene, The Journal of Biological Chemistry, vol.277, issue.5, pp.3176-85 ,
« BMP Signaling in Vascular Development and Disease, Cytokine & Growth Factor Reviews, vol.21, issue.4, pp.287-98, 2010. ,
, Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia, vol.346, p.457
« Bevacizumab as Rescue Treatment for Severe Recurrent Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia, Journal of Clinical Gastroenterology, vol.47, issue.3, pp.256-57, 2013. ,
« Advances in Osteogenin and Related Bone Morphogenetic Proteins in Bone Induction and Repair, Acta Orthopaedica Belgica, vol.58, issue.1, pp.263-67, 1992. ,
« Argon Laser Destruction of Cutaneous Telangiectatic Lesions ». The Laryngoscope 91, pp.1322-1347, 1981. ,
,
« Patterns of Expression of Murine Vgr-1 and BMP-2a RNA Suggest That Transforming Growth Factor-Beta-like Genes Coordinately Regulate Aspects of Embryonic Development, Genes & Development, vol.3, issue.11, pp.1657-68, 1989. ,
« Impact of high-throughput screening in biomedical research », Nature Reviews Drug Discovery, vol.10, p.188 ,
« BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension, American Journal of Human Genetics, vol.68, issue.1, pp.92-102, 2001. ,
« Embolotherapy of Pulmonary Arteriovenous Malformations: Long-Term Results in 112 Patients, Journal of Vascular and Interventional Radiology: JVIR, vol.15, issue.5, pp.451-56, 2004. ,
, Production of a DPP Activity Gradient in the Early Drosophila Embryo through the Opposing Actions of the SOG and TLD Proteins, vol.91, pp.417-443
, Growth Differentiation Factor-9
, Signaling Is Mediated by the Type I Receptor, Activin Receptor-like Kinase 5, Molecular Endocrinology, vol.18, issue.3, pp.653-65, 2004.
,
« Endoglin, a TGF-Beta Binding Protein of Endothelial Cells, Is the Gene for Hereditary Haemorrhagic Telangiectasia Type 1 », Nature Genetics, vol.8, issue.4, pp.345-51, 1994. ,
« Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension: A Randomized Controlled Clinical Trial, Journal of the American College of Cardiology, vol.55, pp.1915-1937 ,
« Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis, Circulation Research, vol.95, issue.8, pp.830-870 ,
,
, Bevacizumab Reverses Need for Liver Transplantation in Hereditary Hemorrhagic Telangiectasia ». Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, vol.14, pp.210-223, 2008.
, Regulation of TGF-? Family Signaling by Inhibitory Smads, vol.9, 2017.
,
, Bone Morphogenetic Protein Receptors and Signal Transduction, vol.147, pp.35-51, 2010.
« Genome-Wide Mechanisms of Smad Binding, Oncogene, vol.32, issue.13, pp.1609-1624 ,
,
« Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells from Patients with Primary Pulmonary Hypertension to Transforming Growth Factor-Beta(1) and Bone Morphogenetic Proteins, Circulation, vol.104, issue.7, pp.790-95, 2001. ,
, Antagonizes Bone Morphogenetic Protein Signaling and Endothelial Cell Differentiation ». Molecular and Cellular Biology, vol.23, issue.16, pp.5664-79, 2003.
« The Right Ventricle in Pulmonary Arterial Hypertension, European Respiratory Review: An Official Journal of the European Respiratory Society, vol.23, issue.134, pp.476-87, 2014. ,
« Transient and Localized Expression of Bone Morphogenetic Protein 4 Messenger RNA during Fracture Healing, Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, vol.9, issue.5, pp.651-59, 1994. ,
« Molecular Genetic Characterization of SMAD Signaling Molecules in Pulmonary Arterial Hypertension, Human Mutation, vol.32, issue.12, pp.1385-89, 2011. ,
, Site-Specific Cleavage of BMP4 by Furin, PC6, and PC7, vol.284, pp.27157-66
, ALK1 Signaling Regulates Early Postnatal Lymphatic Vessel Development, vol.115, pp.1654-61
« Soluble Repulsive Guidance Molecule c/Hemojuvelin Is a Broad Spectrum Bone Morphogenetic Protein (BMP) Antagonist and Inhibits Both BMP2-and BMP6-Mediated Signaling and Gene Expression, The Journal of Biological Chemistry, vol.285, pp.24783-92 ,
,
« Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5 », The Journal of Biological Chemistry, vol.271, pp.21345-52 ,
, et Astrid Ruefli-Brasse. « Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies, vol.7, p.50920, 2012.
Activin receptor-like kinase 1 modulates transforming growth factor-?1 signaling in the regulation of angiogenesis, Proceedings of the National Academy of Sciences of the United States of America 97, vol.14, pp.2626-2657 ,
, Cellular Pathophysiology and Therapy of Pulmonary Hypertension, vol.138, pp.367-77, 2001.
« The Natural History of Symptomatic Arteriovenous Malformations of the Brain: A 24-Year Follow-up Assessment », Journal of Neurosurgery, vol.73, issue.3, pp.387-91, 1990. ,
,
« Silencing of TGF-Beta Signalling by the Pseudoreceptor BAMBI », Nature, vol.401, pp.480-85 ,
, More on Bevacizumab in Hereditary Hemorrhagic Telangiectasia, vol.361, p.931
Systematic Pharmacological Screens Uncover Novel Pathways Involved in Cerebral Cavernous Malformations, EMBO Molecular Medicine, vol.10, p.10, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02335582
Acts as a Quiescence Factor on Tumor Growth, Vessel Normalization and Metastasis in a Mouse Model of Breast Cancer, et Sabine Bailly. « BMP9, but Not BMP10, vol.37, p.209, 2018. ,
« OP-1 CDNA Encodes an Osteogenic Protein in the TGF-Beta Family, The EMBO Journal, vol.9, issue.7, pp.2085-93 ,
« Osteogenic Protein-2. A New Member of the Transforming Growth Factor-Beta Superfamily Expressed Early in Embryogenesis, The Journal of Biological Chemistry, vol.267, pp.25220-25247 ,
« Cardiomyocyte Renewal, The New England Journal of Medicine, vol.361, issue.1, pp.86-88 ,
,
« Origin and evolution of high throughput screening, British journal of pharmacology, vol.152, issue.1, pp.53-61, 2007. ,
, Bone Morphogenetic Proteins Induce Gremlin, a Protein That Limits Their Activity in Osteoblasts, vol.141, pp.4558-63, 2000.
« Is Thalidomide Effective for the Treatment of Gastrointestinal Bleeding in Hereditary Hemorrhagic Telangiectasia?, Haematologica, vol.87, issue.8, p.34, 2002. ,
Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-Occlusive Disease, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.2, pp.189-96 ,
« Cleavage of Chordin by Xolloid Metalloprotease Suggests a Role for Proteolytic Processing in the Regulation of Spemann Organizer Activity, Cell, vol.91, issue.3, pp.80424-80433 ,
« Clinical and Anatomic Outcomes after Embolotherapy of Pulmonary Arteriovenous Malformations, Journal of Vascular and Interventional Radiology: JVIR, vol.17, issue.1, pp.35-44, 2006. ,
, « Inflammation in Pulmonary Arterial Hypertension ». Chest, vol.141, issue.1, pp.210-231, 2012.
« Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension, The New England Journal of Medicine, vol.369, issue.9, pp.809-827 ,
, Drug Repurposing: Progress, Challenges and Recommendations, vol.18, pp.41-58, 2019.
Molecular Pathogenesis of Pulmonary Arterial Hypertension, The Journal of Clinical Investigation, vol.118, issue.7, pp.2372-79, 2008. ,
,
« Erectile-Dysfunction Therapies », Nature Reviews. Drug Discovery, vol.1, issue.9, pp.663-64, 2002. ,
Vein of Galen Aneurysmal Malformation, and Other Fast-Flow Vascular Anomalies Are Caused by RASA1 Mutations, Human Mutation, vol.29, issue.7, pp.959-65, 2008. ,
,
, Cerebral Cavernous Malformation: New Molecular and Clinical Insights, vol.43, pp.716-737, 2006.
, et Sabine Bailly. « BMP9 and BMP10 Are Critical for Postnatal Retinal Vascular Remodeling, vol.119, pp.6162-71
« Purification and Molecular Cloning of a Novel Group of BMPs and Localization of BMP MRNA in Developing Bone, Connective Tissue Research, vol.20, pp.313-332, 1989. ,
« Cloning and Characterization of a Human Type II Receptor for Bone Morphogenetic Proteins, Proceedings of the National Academy of Sciences of the United States of America, vol.92, pp.7632-7668 ,
,
« Bosentan Therapy for Pulmonary Arterial Hypertension, The New England Journal of Medicine, vol.346, pp.896-903 ,
« Long-Term Treatment with Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 Study, vol.140, pp.1274-83, 2011. ,
Fabien Campagne, et Philippe Marambaud. « Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-offunction and improves HHT vascular pathology, Human Molecular Genetics, vol.26, pp.4786-98 ,
Fabien Campagne, et Philippe Marambaud. « A Mouse Model of Hereditary Hemorrhagic Telangiectasia Generated by Transmammary-Delivered Immunoblocking of BMP9 and BMP10 », Scientific Reports, vol.5, p.37366, 2016. ,
« Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function, Circulation Research, vol.93, issue.4, pp.280-91 ,
« Efficacy of Unusually High Doses of Tranexamic Acid for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia, The New England Journal of Medicine, vol.345, p.926, 2001. ,
« DRAGON, a Bone Morphogenetic Protein Co-Receptor », The Journal of Biological Chemistry, vol.280, issue.14, pp.14122-14151 ,
« Bovine Osteogenic Protein Is Composed of Dimers of OP-1 and BMP-2A, Two Members of the Transforming Growth Factor-Beta Superfamily, The Journal of Biological Chemistry, vol.265, pp.13198-205 ,
Nobuhiro Yaoita, et Hiroaki Shimokawa. « Identification of Novel Therapeutic Targets for Pulmonary Arterial Hypertension, International Journal of Molecular Sciences, vol.19, p.12, 2018. ,
« Cyclophilin A Mediates Vascular Remodeling by Promoting Inflammation and Vascular Smooth Muscle Cell Proliferation, Circulation, vol.117, pp.3088-98 ,
« BMP-9 Signals via ALK1 and Inhibits BFGF-Induced Endothelial Cell Proliferation and VEGF-Stimulated Angiogenesis », Journal of Cell Science, vol.120, pp.964-72 ,
« Arterial Endothelium-Specific Activin Receptor-Like Kinase 1 Expression Suggests Its Role in Arterialization and Vascular Remodeling, Circulation Research, vol.93, issue.7, pp.682-89, 2003. ,
,
, et Miikka Vikkula. « Rapamycin and Treatment of Venous Malformations, vol.26, p.185, 2019.
« Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans Progressiva, The New England Journal of Medicine, vol.335, issue.8, pp.555-61 ,
« Role of Vasodilator Testing in Pulmonary Hypertension ». Emerging Trends and Current Controversies in Heart Failure, vol.58, pp.425-458 ,
« A New Nonsense Mutation of SMAD8 Associated with Pulmonary Arterial Hypertension », Journal of Medical Genetics, vol.46, issue.5, pp.331-368, 2009. ,
, Diagnostic Criteria for Hereditary Hemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome), vol.91, pp.66-67
, Hereditary Haemorrhagic Telangiectasia: Pathophysiology, Diagnosis and Treatment, vol.24, pp.203-222, 2010.
,
, Recent Advances in BMP Receptor Signaling, vol.20, pp.343-55, 2009.
Selexipag for the Treatment of Pulmonary Arterial Hypertension, The New England Journal of Medicine, vol.373, pp.2522-2555 ,
EPITOME-2: An Open-Label Study Assessing the Transition to a New Formulation of Intravenous Epoprostenol in Patients with Pulmonary Arterial Hypertension, American Heart Journal, vol.167, issue.2, pp.210-227, 2014. ,
« Regression of Cutaneous and Gastrointestinal Telangiectasia with Sirolimus and Aspirin in a Patient with Hereditary Hemorrhagic Telangiectasia, Annals of Internal Medicine, vol.144, issue.3, pp.226-253 ,
Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension, Pulmonary Circulation, vol.9, issue.2, pp.1-3, 2018. ,
« Increased Susceptibility to Pulmonary Hypertension in Heterozygous BMPR2-Mutant Mice, Circulation, vol.112, issue.4, pp.553-62 ,
,
, Genetics and Genomics of Pulmonary Arterial Hypertension ». Journal of the American College of Cardiology, vol.62, pp.13-21
Anton Vonk Noordegraaf, et al. « Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.192, issue.2, pp.254-57 ,
« Randomised Placebo-Controlled Safety and Tolerability Trial of FK506 (Tacrolimus) for Pulmonary Arterial Hypertension, The European Respiratory Journal, vol.50, p.3, 2017. ,
,
« FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension, The Journal of Clinical Investigation, vol.123, issue.8, pp.3600-3613 ,
« A Mouse Model for Hereditary Hemorrhagic Telangiectasia (HHT) Type 2 », Human Molecular Genetics, vol.12, issue.5, pp.473-82 ,
, The Mouse Retina as an Angiogenesis Model ». Investigative Ophthalmology & Visual Science, vol.51, pp.2813-2839, 2010.
,
« Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease, Circulation, vol.410, pp.2263-73 ,
« Low Dose Intravenous Bevacizumab for the Treatment of Anaemia in Hereditary Haemorrhagic Telangiectasia, British Journal of Haematology, vol.152, issue.4, p.365, 2011. ,
, Regulation of Epidermal Induction by BMP2 and BMP7 Signaling, vol.189, pp.112-134
« Identification of Type I Receptors for Osteogenic Protein-1 and Bone Morphogenetic Protein-4 », The Journal of Biological Chemistry, vol.269, pp.16985-88 ,
« Vascular Anomalies: From Genetics toward Models for Therapeutic Trials ». Cold Spring Harbor Perspectives in Medicine 2, 2012. ,
, Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells, vol.284, pp.15794-804
,
, Formation by Autoinduction ». Science, vol.150, pp.893-99
« Regeneration of an Enchondroma Defect under the Influence of an Implant of Human Bone Morphogenetic Protein, The Journal of Hand Surgery, vol.11, issue.3, pp.80153-80161, 1986. ,
Susumu Itoh, Franck Lebrin, Paschalis Sideras, et Peter ten Dijke. « Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein-Induced Activation of Endothelial Cells, Circulation, vol.106, pp.2263-70 ,
Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2, Cell, vol.87, issue.7, pp.1181-90 ,
, The Sugen 5416/Hypoxia Mouse Model of Pulmonary Hypertension Revisited: Long-Term Follow-Up ». Pulmonary Circulation, vol.4, pp.619-648, 2014.
« Purification and Characterization of Other Distinct Bone-Inducing Factors, Proceedings of the National Academy of Sciences, vol.85, issue.24, pp.9484-88 ,
« Novel homozygous BMP9 nonsense mutation causes pulmonary arterial hypertension: a case report, BMC Pulmonary Medicine, vol.16 ,
,
Germline BMP9 Mutation Causes Idiopathic Pulmonary Arterial Hypertension, The European Respiratory Journal, vol.53, issue.3, 2019. ,
« Pulmonary Arteriovenous Malformations: Techniques and Long-Term Outcome of Embolotherapy, Radiology, vol.169, issue.3, pp.663-69, 1988. ,
« BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia, American Journal of Human Genetics, vol.93, pp.530-567 ,
,
« Novel Regulators of Bone Formation: Molecular Clones and Activities, Science, vol.242, pp.1528-1562 ,
,
, Bone Morphogenetic Protein ». Biochemical and Biophysical Research Communications, vol.362, issue.3, pp.550-53
« A novel piperidine identified by stem cell-based screening attenuates pulmonary arterial hypertension by regulating BMP2 and PTGS2 levels, European Respiratory Journal, vol.51, issue.4, p.1702229, 2018. ,
« Review of Drug Repositioning Approaches and Resources, International Journal of Biological Sciences, vol.14, issue.10, pp.1232-1276, 2018. ,
« Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 Myoblasts, Biochemical and Biophysical Research Communications, vol.238, issue.2, pp.574-80 ,
,
Bone Morphogenetic Protein-9 Inhibits Lymphatic Vessel Formation via Activin Receptor-like Kinase 1 during Development and Cancer Progression, Proceedings of the National Academy of Sciences of the United States of America, vol.110, pp.18940-18985, 2013. ,
« Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-Specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells, The Journal of Biological Chemistry, vol.280, pp.24443-50 ,
« Dysfunctional Voltage-Gated K+ Channels in Pulmonary Artery Smooth Muscle Cells of Patients with Primary Pulmonary Hypertension, Circulation, vol.98, issue.14, pp.1400-1406 ,
, et Zhenggang Bi. « Recombinant BMP, vol.4, issue.7
, Fusion Protein Induces Differentiation of Bone Marrow Stem Cells, vol.112, pp.3054-60, 2011.
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147 », Journal of Biological Chemistry, vol.277, pp.22959-65 ,
« Phenotypic screens as a renewed approach for drug discovery ». Drug discovery today 18, pp.1067-73, 2013. ,
« A rapid and sensitive bioassay to measure bone morphogenetic protein activity, BMC Cell Biology, vol.8, issue.1, p.41, 2007. ,
, Annals of Surgery, vol.10, issue.5, pp.352-68
, , 2019.
, Origine et évolution de l'appareil respiratoire aérien des Vertébrés -EM|consulte